- Report
- June 2026
- 121 Pages
Mexico
From €3630EUR$3,999USD£3,127GBP
- Report
- June 2026
- 121 Pages
Mexico
From €3630EUR$3,999USD£3,127GBP
- Report
- June 2026
- 138 Pages
United Kingdom
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 143 Pages
Thailand
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 143 Pages
India
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 147 Pages
India
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 148 Pages
Germany
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 143 Pages
Russia
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 143 Pages
China
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 142 Pages
Japan
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 150 Pages
Saudi Arabia
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 141 Pages
Turkey
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 136 Pages
Italy
From €3630EUR$3,999USD£3,127GBP
- Report
- April 2026
- 141 Pages
Spain
From €3630EUR$3,999USD£3,127GBP
- Report
- March 2026
- 136 Pages
France
From €3630EUR$3,999USD£3,127GBP
- Report
- February 2026
- 149 Pages
Canada
From €3630EUR$3,999USD£3,127GBP
- Report
- February 2026
- 141 Pages
India
From €3630EUR$3,999USD£3,127GBP
- Report
- February 2026
- 137 Pages
Australia
From €3630EUR$3,999USD£3,127GBP
- Report
- January 2025
- 135 Pages
Global
From €3630EUR$3,999USD£3,127GBP
- Report
- July 2024
- 138 Pages
Brazil
From €3630EUR$3,999USD£3,127GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more